T he US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as ...

Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to healthcare providers and a recall by one manufacturer, according to a January ...

neffy 2 mg is for the treatment of Type I Allergic Reactions, including anaphylaxis, in adults and children who weigh ≥30 kg (66 lbs.). It is the first and only FDA-approved epinephrine nasal ...

ARS Pharmaceuticals has announced the submission of applications seeking the approval of the 2mg epinephrine nasal spray, neffy, in the UK and Canada. Set to be marketed as ‘EURneffy’ in these ...